Literature DB >> 23960623

Percutaneous coronary intervention of a saphenous vein graft ostial stenosis in a patient with Bentall procedure.

Mohammed Mukhaini1, Prashanth Panduranga.   

Abstract

Composite graft replacement of the aortic root and coronary reimplantation with or without coronary artery bypass surgery is the standard treatment for a variety of aortic root pathologies. Previously, percutaneous coronary intervention of either reimplanted coronary arteries or left/right coronary artery through cabrol graft has been described in post-Bentall patients. We describe percutaneous coronary intervention of a saphenous vein graft ostial stenosis in a patient with previous Bentall procedure and a vein graft to right coronary artery, which was complex and challenging.

Entities:  

Keywords:  Bentall procedure; Percutaneous coronary intervention; Vein graft stenosis

Year:  2010        PMID： 23960623      PMCID： PMC3727551          DOI： 10.1016/j.jsha.2010.06.001

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN： 1016-7315


  10 in total

1.  Treatment of saphenous vein graft lesions with drug-eluting stents: immediate and midterm outcome.

Authors:  Lei Ge; Ioannis Iakovou; Giuseppe M Sangiorgi; Alaide Chieffo; Gloria Melzi; John Cosgrave; Matteo Montorfano; Iassen Michev; Flavio Airoldi; Mauro Carlino; Nicola Corvaja; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

2.  Emergent percutaneous intervention with a drug-eluting stent of a cabrol graft-to-left main anastomosis during a non-ST-elevation infarction in a patient with Marfan's syndrome.

Authors:  Farrukh Hussain; John Ducas; Tirath Gosal
Journal:  J Invasive Cardiol       Date:  2006-09       Impact factor: 2.022

3.  Bilateral coronary ostial stenoses post-Bentall procedure: management options in the DES era.

Authors:  Matthew I Worthley; John Burgess; Mouheiddin Traboulsi
Journal:  J Invasive Cardiol       Date:  2005-12       Impact factor: 2.022

4.  Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.

Authors:  Paul Vermeersch; Pierfrancesco Agostoni; Stefan Verheye; Paul Van den Heuvel; Carl Convens; Nico Bruining; Frank Van den Branden; Glenn Van Langenhove
Journal:  J Am Coll Cardiol       Date:  2006-11-28       Impact factor: 24.094

5.  A technique for complete replacement of the ascending aorta.

Authors:  H Bentall; A De Bono
Journal:  Thorax       Date:  1968-07       Impact factor: 9.139

6.  Long-term clinical outcome after stent implantation in saphenous vein grafts.

Authors:  P P de Jaegere; R T van Domburg; P J Feyter; P N Ruygrok; W J van der Giessen; M J van den Brand; P W Serruys
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

7.  Patency of saphenous vein coronary artery bypass grafts from the vascular prosthesis of the ascending aorta.

Authors:  Hidenori Sako; Tetsuo Hadama; Osamu Shigemitsu; Shinji Miyamoto; Hirofumi Anai; Tomoyuki Wada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2003-06       Impact factor: 1.520

8.  Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.

Authors:  Darpan Bansal; Raghu Muppidi; Sandeep Singla; Rishi Sukhija; Stuart Zarich; Jawahar L Mehta; Rajesh Sachdeva
Journal:  Catheter Cardiovasc Interv       Date:  2008-01-01       Impact factor: 2.692

9.  Fate of coronary ostial anastomoses after the modified Bentall procedure.

Authors:  Aldo D Milano; Stefano Pratali; Gianclaudio Mecozzi; Piero Boraschi; Giovanni Braccini; Enrico Magagnini; Uberto Bortolotti
Journal:  Ann Thorac Surg       Date:  2003-06       Impact factor: 4.330

10.  Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.

Authors:  Paul Vermeersch; Pierfrancesco Agostoni; Stefan Verheye; Paul Van den Heuvel; Carl Convens; Frank Van den Branden; Glenn Van Langenhove
Journal:  J Am Coll Cardiol       Date:  2007-06-13       Impact factor: 24.094
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.